NCT06868732 2025-03-11
Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1 Not yet recruiting
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.